Christine Hunt, DO
Pain Medicine · Jacksonville, FLNPI 1447678628
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.5%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 33.6% of the total. Reporting peaked in 2023 at $2,353 and has fallen 94.7% since, to $124 in 2025.
Across 43 payments — averaging $155.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Stratus Medical, LLC$2K
- Nevro Corp.$1K
- SPR Therapeutics, Inc$534
- Abbott$310
- Nalu Medical, Inc.$166
- plus $123 from 3 others
Across 14 payments — averaging $9645.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$124K
- Nevro Corp.$11K
What the payments were for
- Grants$2,02630%
- Travel & lodging$1,09116%
- Food & beverage$3,58153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 6 | $2,250 |
| Stratus Medical, LLC | 10 | $2,024 |
| Nevro Corp. | 12 | $1,292 |
| SPR Therapeutics, Inc | 7 | $534 |
| Abbott | 4 | $310 |
| Nalu Medical, Inc. | 1 | $166 |
| Heron Therapeutics, Inc. | 1 | $81 |
| Vertex | 1 | $31 |
| Stryker | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nimbus$1,893
- SYNCHROMED$1,875
- Senza$443
- Omnia$239
- Senza II$221
- INTELLIS ADAPTIVESTIM$177
- Nalu Neurostimulation System$166
- SYNCHROMEDII$151
- S-Series SCS Leads$133
- SPRINT PNS System$121
- ETERNA$108
How this compares
$6,698 in reported general payments places this provider in the 70th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 35 | $1,182 |
| Gabapentin | 27 | $443 |
| Duloxetine Hcl | 24 | $172 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Jacksonville
- Mark-Friedrich HurdleJacksonville$140K
- Orlando FloreteJacksonville$86K
- Christopher NetzelJacksonville$34K
- Andrew MedvedovskyJacksonville$32K
- Sahil GuptaJacksonville$19K
- Pavel BalduyeuJacksonville$18K
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.